← FDA DRUG APPROVALS

FDA ANDA · ANDA040337

TRIHEXYPHENIDYL HYDROCHLORIDE

Sponsor: HIKMA

APPLICATION
ANDA040337
TYPE
ANDA
ORIGINAL APPROVAL
2000-02-16
LATEST ACTION
2000-11-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIHEXYPHENIDYL HYDROCHLORIDEDiscontinued
TRIHEXYPHENIDYL HYDROCHLORIDE 2MG · TABLET · ORAL
TRIHEXYPHENIDYL HYDROCHLORIDEDiscontinued
TRIHEXYPHENIDYL HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2000-11-14Labeling · Supplement 2AP
2000-11-14Manufacturing (CMC) · Supplement 3AP
2000-11-14Manufacturing (CMC) · Supplement 1AP
2000-02-16OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →